Literature DB >> 15519506

Cutaneous malignant melanoma in Europe.

Esther de Vries1, Jan Willem Coebergh.   

Abstract

Cutaneous malignant melanoma is on the rise in fair skinned societies. Both its incidence and mortality rates have been increasing in Europe over the past decades, the latter seem to stabilise in Scandinavia. The main cause of melanoma is intermittent exposure to ultraviolet radiation, especially in combination with endogenous factors like skin type and genetic predisposition. Evidence on an association between sunbed use and melanoma is inconclusive, but seems to point to a slightly increased risk associated with sunbed use. Within Europe, considerably variation in patterns of melanoma incidence and mortality existed. In this paper, we discuss the possible explanations for the observed trends and options for primary and secondary prevention. Early detection seems the most promising way to combat the relatively poor survival rates in Southern and Eastern Europe.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15519506     DOI: 10.1016/j.ejca.2004.06.003

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  49 in total

1.  Sensitivity of Preference-Based Quality-of-Life Measures for Economic Evaluations in Early-Stage Melanoma.

Authors:  Mbathio Dieng; Nadine A Kasparian; Anne E Cust; Daniel S J Costa; Anh Tran; Phyllis N Butow; Scott W Menzies; Graham J Mann; Rachael L Morton
Journal:  JAMA Dermatol       Date:  2018-01-01       Impact factor: 10.282

Review 2.  Comparison of dermoscopy and reflectance confocal microscopy for the diagnosis of malignant skin tumours: a meta-analysis.

Authors:  Yi-Quan Xiong; Shu-Juan Ma; Yun Mo; Shu-Ting Huo; Yu-Qi Wen; Qing Chen
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-13       Impact factor: 4.553

Review 3.  Skin cancer and vitamin D: an update.

Authors:  Candy Wyatt; Rachel E Neale; Robyn M Lucas
Journal:  Melanoma Manag       Date:  2015-02-25

4.  Immunotoxins: a promising treatment modality for metastatic melanoma?

Authors:  Karianne Risberg; Oystein Fodstad; Yvonne Andersson
Journal:  Ochsner J       Date:  2010

5.  The radial growth phase of malignant melanoma: multi-phase modelling, numerical simulations and linear stability analysis.

Authors:  P Ciarletta; L Foret; M Ben Amar
Journal:  J R Soc Interface       Date:  2010-07-23       Impact factor: 4.118

6.  Trends in skin cancer incidence by socioeconomic position in Scotland, 1978-2004.

Authors:  V R Doherty; D H Brewster; S Jensen; D Gorman
Journal:  Br J Cancer       Date:  2010-05-04       Impact factor: 7.640

7.  The role of spectrophotometry in the diagnosis of melanoma.

Authors:  Paolo A Ascierto; Marco Palla; Fabrizio Ayala; Ileana De Michele; Corrado Caracò; Antonio Daponte; Ester Simeone; Stefano Mori; Maurizio Del Giudice; Rocco A Satriano; Antonio Vozza; Giuseppe Palmieri; Nicola Mozzillo
Journal:  BMC Dermatol       Date:  2010-08-13

Review 8.  Melanoma treatment costs: a systematic review of the literature, 1990-2011.

Authors:  Gery P Guy; Donatus U Ekwueme; Florence K Tangka; Lisa C Richardson
Journal:  Am J Prev Med       Date:  2012-11       Impact factor: 5.043

Review 9.  Epidemiology of invasive cutaneous melanoma.

Authors:  R M MacKie; A Hauschild; A M M Eggermont
Journal:  Ann Oncol       Date:  2009-08       Impact factor: 32.976

10.  PPARbeta activation inhibits melanoma cell proliferation involving repression of the Wilms' tumour suppressor WT1.

Authors:  Jean-François Michiels; Christophe Perrin; Nathalie Leccia; Daniela Massi; Paul Grimaldi; Nicole Wagner
Journal:  Pflugers Arch       Date:  2010-01-12       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.